Heart disease

Minimising the risk of cardiovascular disease (updated)

Cover image

This Treataware fact sheet explains the current knowledge about cardiovascular (heart) disease risk in people living with HIV/AIDS, and some strategies for minimising risk.

Abacavir and heart attacks

Latest results presented by investigators at the CROI meeting in February in Boston suggested that treatment with abacavir (also found in the combination pills Kivexa and Trizivir) and ddI (didanosine, Videx) may significantly increase the risk of myocardial infarction, or heart attack.

HIV treatment, weight and low income risk factors for heart disease in positive people

HIV-positive people need to be targeted for heart disease screening and treatment, according to one of the largest studies of HIV and cardiac health ever conducted; published in the October 15th edition of Clinical Infectious Diseases.

CROI 2007: A great leap forward

A major scientific conference on HIV has wound up with promising news on treatments which could signal a significant improvement in HIV treatment for the first time in some years.

ASHM 2006: Spotlight on Sculptra

The annual conference of the Australasian Society for HIV Medicine (ASHM) was held in Melbourne in November. This article summarises some key developments.

Rocky Mountain CROI

 The 13th annual Conference on Retroviruses and Opportunistic Infections (CROI) took place in Denver, Colorado, from February 5 to 8. The major breaking news from this conference was the premature cancellation of the SMART study, but as usual, this important conference produced a great deal more than a single story.

Factors to discuss with your doctor when considering your choice of Antiretroviral Drugs

ATPA fact sheet - ARVs

This Treataware fact sheet is a quick reference to the factors people with HIV and their doctors need to consider when choosing an antiretroviral treatment regimen.

My toxic world

The beautiful beaches of Rio de Janeiro are hardly the place in which you’d imagine your thoughts would start turning to mortality, but for a while there not even the incredible, hunky, tanned Adonises strutting before me could distract me from thoughts of impending doom.

The bleeding edge

The annual Retrovirus Conference is a key event on the HIV scientific calendar, and regularly highlights the most exciting ‘bleeding edge’ developments from the world of HIV science.

News and treatments briefs

 HIV-related news in brief from the Oct-Nov 2003 edition of Positive Living.